Knowledge, Attitudes and Practices Regarding 2009 H1N1 Vaccine Among Patients Hospitalized With Influenza A (H1N1) pdm09
نویسندگان
چکیده
Background: Although previous studies have assessed barriers to influenza vaccination in general populations, few studies have assessed barriers among ill persons to inform prevention programs. Methods: We conducted a telephone survey of patients hospitalized with laboratory-confirmed 2009 H1N1infection from December 2009 through April 2010 to evaluate pandemicvaccination coverage and identify attitudes and barriers to vaccination. Patients were asked to describe chronic medical conditions, healthcare-seeking behavior, 2009 H1N1 vaccination status, reason(s) and information that guided vaccine decision-making, and perceptions of risk of 2009 H1N1, vaccine safety and effectiveness. Results: We interviewed 146 of 364 (40%) patients hospitalized with 2009 H1N1 in the state of Georgia.Fifteen (10%) patients received 2009 H1N1 vaccine before hospitalization. Although 109 (75%) respondents were in an Advisory Committee on Immunization Practices(ACIP) target group for 2009 H1N1 vaccination, only 54 (50%) were aware they should be vaccinated. Reasons for not receiving vaccination included concerns about vaccine safety or effectiveness (34%) and perception of risk of 2009 H1N1 (26%). Only 55 (38%) patients reported discussing 2009 H1N1 vaccination with their clinician; a significantly higher proportion of vaccinated than unvaccinated patients reported having a discussion with their clinician about vaccination (p=0.002). Conclusions: To our knowledge, this study is the first to evaluate reasons for non-vaccination among persons hospitalized for influenza. Reasons for not being vaccinated includedconcerns aboutvaccine safety,unawareness of being in an ACIP target group, and unawareness of risk of severe outcomes from influenza. Our study characterized numerous missed opportunities for prevention, and identified a clear need for increased patient and clinician education regarding influenza vaccines. *Corresponding authors: Heidi A Davidson, Influenza Division, Centers for Disease Control and Prevention, 4770 Buford Highway, MS E-85, Chamblee, GA 30341, USA, Tel: (404) 498-0395; E-mail: [email protected] David Swerdlow, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MSA-27, Atlanta, GA 30333, USA, Tel: (404) 639-1329; E-mail: [email protected] Received November 08, 2013; Accepted December 02, 2013; Published December 05, 2013 Citation: Davidson HA, Kennedy E, Jhung MA, Drenzek C, Reeves A, et al. (2013) Knowledge, Attitudes and Practices Regarding 2009 H1N1 Vaccine Among Patients Hospitalized With Influenza A (H1N1) pdm09. Virology & Mycology S2: 002. doi:10.4172/2161-0517.S2-002 Copyright: © 2013 Davidson HA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
منابع مشابه
Antigenic Variation of the Haemagglutinin Gene of the Influenza A (H1N1) pdm09 Virus Circulating in Shiraz, February-April 2013
Background: A new pandemic influenza A (H1N1) emerged in April 2009, causing considerable morbidity and mortality. Since mutations in the haemagglutinin (HA) may influence the antigenicity and pathogenicity of the virus, continued epidemiological and molecular characterization for the effective control of pandemic flu and developing of more appropriate vaccine is crucial. Objective: To monitor ...
متن کاملReturn of pandemic H1N1 influenza virus
BACKGROUND Influenza pandemics are usually caused by the re-assortment of several influenza viruses, results in the emergence of new influenza virus strains that can infect the entire population. These pandemic strains, as well as seasonal influenza viruses, are subjected to extensive antigenic change that has, so far, prevented the generation of a universal vaccine. METHODS Samples of patien...
متن کاملInfluenza A(H1N1)pdm09-related pneumonia and other complications.
Influenza A(H1N1)pdm09 virus infection was associated with significant morbidity, mainly among children and young adults. The majority of patients had self-limited mild-to-moderate uncomplicated disease. However, some patients developed severe illness and some died. In addition to respiratory complications, several complications due to direct and indirect effects on other body systems were asso...
متن کاملNo Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009
We conducted a population-based study in Manitoba, Canada, to investigate whether use of inactivated trivalent influenza vaccine (TIV) during the 2008-09 influenza season was associated with subsequent infection with influenza A(H1N1)pdm09 virus during the first wave of the 2009 pandemic. Data were obtained from a provincewide population-based immunization registry and laboratory-based influenz...
متن کاملDid the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?
BACKGROUND The extent to which A(H1N1)pdm09 influenza vaccines prevented hospital admissions with pneumonia and influenza (P&I) during the 2009 pandemic remains poorly understood. We evaluated the effectiveness of the A(H1N1)pdm09 and seasonal influenza vaccines (TIV) used during the 2009 mass vaccination campaign in Manitoba (Canada) in preventing P&I hospitalization. METHODS A population-ba...
متن کامل